share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Plenge Robert M

SEC announcement ·  Mar 13 09:24
Summary by Futu AI
On March 10, 2024, Robert M. Plenge, EVP and Chief Research Officer at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Plenge acquired a total of 9,143 shares through the exercise or conversion of derivative securities at no cost. Concurrently, he disposed of 4,754 shares, with a portion of the disposals (2,965 shares) used to cover exercise prices or tax liabilities at an average price of $53.79 per share, amounting to a total market value of $105,697.35. After these transactions, Plenge directly held 11,315 shares of Bristol-Myers Squibb. Additionally, he indirectly held 1,856.842 shares through a savings and investment program and a family trust.
On March 10, 2024, Robert M. Plenge, EVP and Chief Research Officer at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Plenge acquired a total of 9,143 shares through the exercise or conversion of derivative securities at no cost. Concurrently, he disposed of 4,754 shares, with a portion of the disposals (2,965 shares) used to cover exercise prices or tax liabilities at an average price of $53.79 per share, amounting to a total market value of $105,697.35. After these transactions, Plenge directly held 11,315 shares of Bristol-Myers Squibb. Additionally, he indirectly held 1,856.842 shares through a savings and investment program and a family trust.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.